Bakare Oladapo, Ashendel Curtis L, Peng Hairuo, Zalkow Leon H, Burgess Edward M
Department of Chemistry, Howard University, 525 College Street, Washington, DC 20059, USA.
Bioorg Med Chem. 2003 Jul 17;11(14):3165-70. doi: 10.1016/s0968-0896(03)00267-0.
Mitogen activated protein kinases are of interest as research tools and as therapeutic target for certain physiological disorders. In this study, we found 2-chloro-3-(N-succinimidyl)-1,4-naphthoquinone 6 to be a selective inhibitor of MEK1 with an IC(50) of 0.38 microM. An open-chain homologue, 10, showed selective cytotoxicity against renal cancer in the NCI in vitro tumor screening. Structure-activity relationship study of eight compounds showed the cyclic imido-substituted chloro-1,4-naphthoquinone as more potent and selective MEK1 inhibitors than the open chain homologues. The imido-substituted chloro-1,4-naphthoquinones were synthesized in a straightforward fashion by refluxing 2-amino-3-chloro-1,4-naphthoquinone with the appropriate acid chloride or diacyl dichloride.